Antibody-mediated protection against symptomatic COVID achieved at low serum neutralizing titers

By | October 24, 2022
In a recent study posted to the medRxiv* preprint server, researchers in the United States assessed the efficiency of protection mediated by antibodies against symptomatic coronavirus disease 2019 (COVID-19) at low serum-neutralizing titers.